EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cardioprotective properties of OMT-28, a synthetic analog of omega-3 epoxyeicosanoids

Joshua Kranrod, Anne Konkel, Robert Valencia, Ahmed M Darwesh, Robert Fischer, Wolf-Hagen Schunck, John M Seubert

Journal of Biological Chemistry · 2024-06 · 300 (6) · 107372

DOI: 10.1016/j.jbc.2024.107372 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2024-06. Verfasst von Joshua Kranrod und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy and Pharmaceutical Sciences, College of Health Sciences, University of Alberta, Edmonton, Alberta, Canada; Cardiovascular Researc…. Hauptthemen laut MEDLINE: Myocytes, Cardiac, Cardiotonic Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OMT-28 is a metabolically robust small molecule developed to mimic the structure and function of omega-3 epoxyeicosanoids. However, it remained unknown to what extent OMT-28 also shares the cardioprotective and anti-inflammatory properties of its natural counterparts. To address this question, we analyzed the ability of OMT-28 to ameliorate hypoxia/reoxygenation (HR)-injury and lipopolysaccharide (LPS)-induced endotoxemia in cultured cardiomyocytes. Moreover, we investigated the potential of OMT-28 to limit functional damage and inflammasome activation in isolated perfused mouse hearts subjected to ischemia/reperfusion (IR) injury. In the HR model, OMT-28 (1 μM) treatment largely preserved cell viability (about 75 versus 40% with the vehicle) and mitochondrial function as indicated by the maintenance of NAD+/NADH-, ADP/ATP-, and respiratory control ratios. Moreover, OMT-28 blocked the HR-induced production of mitochondrial reactive oxygen species. Pharmacological inhibition experiments suggested that Gαi, PI3K, PPARα, and Sirt1 are essential components of the OMT-28-mediated pro-survival pathway. Counteracting inflammatory injury of cardiomyocytes, OMT-28 (1 μM) reduced LPS-induced increases in TNFα protein (by about 85% versus vehicle) and NF-κB DNA binding (by about 70% versus vehicle). In the ex vivo model, OMT-28 improved post-IR myocardial function recovery to reach about 40% of the baseline value compared to less than 20% with the vehicle. Furthermore, OMT-28 (1 μM) limited IR-induced NLRP3 inflammasome activation similarly to a direct NLRP3 inhibitor (MCC950). Overall, this study demonstrates that OMT-28 possesses potent cardio-protective and anti-inflammatory properties supporting the hypothesis that extending the bioavailability of omega-3 epoxyeicosanoids may improve their prospects as therapeutic agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocytes, CardiacCardiotonic AgentsAnimalsMiceInflammasomesMyocardial Reperfusion InjuryLipopolysaccharidesMaleNLR Family, Pyrin Domain-Containing 3 ProteinMice, Inbred C57BLSirtuin 1Anti-Inflammatory AgentsReactive Oxygen SpeciesFatty Acids, Omega-3Endotoxemia

Stichwörter der Autor:innen

17,18-EEQOMT-28analogcardioprotectioneicosanoidoxylipin

Substanzen

Cardiotonic AgentsInflammasomesLipopolysaccharidesNLR Family, Pyrin Domain-Containing 3 ProteinSirtuin 1Anti-Inflammatory AgentsReactive Oxygen SpeciesFatty Acids, Omega-3Nlrp3 protein, mouse

Autor:innen und Institutionen

  • Faculty of Pharmacy and Pharmaceutical Sciences, College of Health Sciences, University of Alberta, Edmonton, Alberta, Canada; Cardiovascular Research Institute, University of Alberta, Edmonton, Alberta, Canada.
  • OMEICOS Therapeutics GmbH, Berlin, Germany.
  • Cardiovascular Research Institute, University of Alberta, Edmonton, Alberta, Canada; Faculty of Medicine and Dentistry, Department of Pharmacology, College of Health Sciences, University of Alberta, Edmonton, Alberta, C…
  • Faculty of Pharmacy and Pharmaceutical Sciences, College of Health Sciences, University of Alberta, Edmonton, Alberta, Canada.
  • Max Delbrueck Center for Molecular Medicine, Berlin, Germany.
  • Faculty of Pharmacy and Pharmaceutical Sciences, College of Health Sciences, University of Alberta, Edmonton, Alberta, Canada; Cardiovascular Research Institute, University of Alberta, Edmonton, Alberta, Canada; Faculty…

Zitieren

APA

Kranrod, J., Konkel, A., Valencia, R., Darwesh, A. M., Fischer, R., Schunck, W. H., & Seubert, J. M. (2024). Cardioprotective properties of OMT-28, a synthetic analog of omega-3 epoxyeicosanoids. Journal of Biological Chemistry, 300(6), 107372. https://doi.org/10.1016/j.jbc.2024.107372

Vancouver

Kranrod J, Konkel A, Valencia R, Darwesh AM, Fischer R, Schunck WH, et al. Cardioprotective properties of OMT-28, a synthetic analog of omega-3 epoxyeicosanoids. Journal of Biological Chemistry. 2024;300(6):107372. doi:10.1016/j.jbc.2024.107372

BibTeX
@article{Kranrod2024,
  author = {Kranrod, Joshua and Konkel, Anne and Valencia, Robert and Darwesh, Ahmed M and Fischer, Robert and Schunck, Wolf-Hagen and Seubert, John M},
  title = {Cardioprotective properties of OMT-28, a synthetic analog of omega-3 epoxyeicosanoids},
  journal = {Journal of Biological Chemistry},
  year = {2024},
  volume = {300},
  number = {6},
  pages = {107372},
  doi = {10.1016/j.jbc.2024.107372}
}
Kostenlos starten →